Cofactor Genomics: Chris Parker, Jarret Glasscock

Cofactor Genomics has appointed Chris Parker as CEO and a member of the company's board of directors, replacing former CEO Jarret Glasscock, a Cofactor Genomics founder who will transition into the role of president, chief technology officer, and board member. Most recently, Parker was chief business officer at Adela, a developer of blood tests for cancer. Prior to that he worked for Exact Sciences, where he served as VP of business development and, earlier, VP of integrations. He has also previously held executive leadership roles at Cellular Dynamics and Affymetrix, and has served as a board member for several companies. Cofactor said that it made the transition in preparation for accelerated commercial growth and increased patient access for its OncoPrism molecular test for checkpoint inhibitor immunotherapy response, which received Medicare coverage in October.